Resideo Q1 2026 slides: earnings beat masks cash flow pressure

Resideo beat Q1 2026 expectations with EPS of $0.65 vs. $0.60 consensus and revenue of $1.91 billion vs. $1.88 billion, while adjusted EBITDA rose 28% to $215 million. However, cash flow weakened sharply to a $140 million use, free cash flow was -$109 million, and income from operations fell 25% to $102 million, contributing to a 1.57% after-hours decline. Management reaffirmed full-year 2026 guidance of $7.8-7.9 billion revenue and $3.00-3.20 adjusted EPS while outlining plans to split into two public companies.

Analysis

The market is likely keying off a quality-of-earnings problem, not the headline beat. EBITDA can grow while equity still de-rates if working capital absorbs cash and leverage stays sticky; that is especially true heading into a separation, when investors discount execution risk twice: once for transition friction and again for stranded cost uncertainty. The cash burn also matters because it reduces optionality for buybacks, debt paydown, and any pre-spin reinvestment, which means management’s “value unlock” story depends on a clean capital structure months from now, not on current operating momentum.

The more interesting second-order effect is that the separation could create a cleaner winner/loser split than the consolidated entity suggests today. The manufacturing asset likely deserves a higher multiple if margin expansion proves durable and investor day reveals more pricing power than feared; the distribution asset, by contrast, may face continued margin pressure if fuel, freight, and competitive pass-through remain sticky. That creates a classic spin setup where the higher-quality asset is cross-subsidizing a lower-multiple business inside one ticker, and the market tends to only fully recognize that after standalone financials are published.

The biggest risk is timing: over the next 1-2 quarters, the stock can remain range-bound if cash conversion does not normalize, because separation narratives usually fail when FCF is negative into the event. The upside catalyst is the July investor days, which should force the market to underwrite two distinct capital allocation stories; if management can show a path to normalized cash conversion and lower stranded costs, the current discount could narrow quickly. Conversely, any further drawdown in cash or evidence the distribution business is structurally weaker than expected would likely hit the stock harder than the EBITDA beat can offset.

Consensus appears to be underestimating how much of the move has already priced in operational improvement, while still overestimating the immediate value unlock from the split. In our view, this is not an obvious long until the cash burn inflects; however, the setup may be attractive as a relative-value long in the better-quality segment against the parent until the market separates the pieces. The after-hours dip suggests the street is demanding proof, not promise, which often creates a better entry after the first investor-day reset rather than on the initial earnings print.

Key Decisions for Investors

• Do not chase REZI ahead of the July investor days; wait for evidence of working-capital normalization and stand-alone cost structure disclosure. Risk/reward improves materially only if the stock weakens on separation complexity rather than re-rates on narrative alone.
• If long REZI, size it as an event-driven position with a 1-2 quarter horizon and a tight risk budget; the stock can work if investor day reveals credible FCF inflection, but downside is amplified if cash burn persists. Use a staggered entry closer to $34-35 rather than after a one-day relief rally.
• Consider a relative-value long REZI vs. a lower-quality industrial/distribution proxy or short basket of levered distributors if you want to express the margin-quality split. The thesis is that the manufacturing business should command a higher multiple than the consolidated entity once standalone metrics are disclosed.
• For options, prefer a post–investor-day call spread over outright common if you want upside to separation re-rating with limited downside. Structure it for 2-4 months out to capture the July catalyst while avoiding bleed from a slow cash-flow story.
• Avoid using REZI as a straight beta long into a macro-sensitive tape; with elevated volatility, the stock is more likely to trade on FCF and separation execution than on broad market direction over the next several weeks.